SE8003253L - USE OF POLYPEPTIDE FRACTIONS AS A DRUG - Google Patents

USE OF POLYPEPTIDE FRACTIONS AS A DRUG

Info

Publication number
SE8003253L
SE8003253L SE8003253A SE8003253A SE8003253L SE 8003253 L SE8003253 L SE 8003253L SE 8003253 A SE8003253 A SE 8003253A SE 8003253 A SE8003253 A SE 8003253A SE 8003253 L SE8003253 L SE 8003253L
Authority
SE
Sweden
Prior art keywords
drug
polypeptide fractions
polypeptide
fractions
Prior art date
Application number
SE8003253A
Other languages
Swedish (sv)
Other versions
SE431215B (en
Inventor
U S E Rothman
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8003253A priority Critical patent/SE431215B/en
Priority to AT81901117T priority patent/ATE8740T1/en
Priority to EP81901117A priority patent/EP0050636B1/en
Priority to DE8181901117T priority patent/DE3165190D1/en
Priority to JP56501488A priority patent/JPH0453849B2/ja
Priority to US06/336,400 priority patent/US4550020A/en
Priority to PCT/SE1981/000130 priority patent/WO1981003124A1/en
Priority to AU71522/81A priority patent/AU546018B2/en
Publication of SE8003253L publication Critical patent/SE8003253L/en
Priority to DK577181A priority patent/DK158334C/en
Priority to FI814188A priority patent/FI814188L/en
Publication of SE431215B publication Critical patent/SE431215B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07G—COMPOUNDS OF UNKNOWN CONSTITUTION
    • C07G99/00—Subject matter not provided for in other groups of this subclass
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
SE8003253A 1980-04-29 1980-04-29 Polypeptide fraction isolated from the haemolymph of the common mussel for use as an antiviral medicine SE431215B (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
SE8003253A SE431215B (en) 1980-04-29 1980-04-29 Polypeptide fraction isolated from the haemolymph of the common mussel for use as an antiviral medicine
US06/336,400 US4550020A (en) 1980-04-29 1981-04-29 Polypeptide fractions from mussel for medical use
EP81901117A EP0050636B1 (en) 1980-04-29 1981-04-29 A polypeptide fraction for use as an antimicrobial drug
DE8181901117T DE3165190D1 (en) 1980-04-29 1981-04-29 A polypeptide fraction for use as an antimicrobial drug
JP56501488A JPH0453849B2 (en) 1980-04-29 1981-04-29
AT81901117T ATE8740T1 (en) 1980-04-29 1981-04-29 POLYPEPTIDE FRACTION FOR USE AS ANTIMICROBIAL MEDICINAL PRODUCT.
PCT/SE1981/000130 WO1981003124A1 (en) 1980-04-29 1981-04-29 Polypeptide fraction from mussel for medical use
AU71522/81A AU546018B2 (en) 1980-04-29 1981-04-29 Polypeptide fraction from mussel for medical use
DK577181A DK158334C (en) 1980-04-29 1981-12-23 PROCEDURE FOR PREPARING MUSCLE POLYPEPTIME FRACTIONS
FI814188A FI814188L (en) 1980-04-29 1981-12-29 ANVAENDNING AV POLYPEPTIDFRAKTIONER SOM LAEKEMEDEL

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8003253A SE431215B (en) 1980-04-29 1980-04-29 Polypeptide fraction isolated from the haemolymph of the common mussel for use as an antiviral medicine

Publications (2)

Publication Number Publication Date
SE8003253L true SE8003253L (en) 1981-10-30
SE431215B SE431215B (en) 1984-01-23

Family

ID=20340871

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8003253A SE431215B (en) 1980-04-29 1980-04-29 Polypeptide fraction isolated from the haemolymph of the common mussel for use as an antiviral medicine

Country Status (1)

Country Link
SE (1) SE431215B (en)

Also Published As

Publication number Publication date
SE431215B (en) 1984-01-23

Similar Documents

Publication Publication Date Title
PT73686A (en) PHARMACEUTICAL FORMULATION
FI71168B (en) FOERFARANDE FOER FRAMSTAELLNING AV ML-236B-DERIVAT VILKA ANVAENDS SOM CEEEMEDELEL
FR2483237B1 (en) SYRINGE
DK148939C (en) STAIRCASE
FI791456A (en) PHARMACEUTICAL FORM
FI810056L (en) PHARMACEUTICAL FORM
FI790404A (en) PHARMACEUTICAL SAMMANSAETTNINGAR
FI813527L (en) MACROIDANTIBIOTICS OF FOERBAETTRADE
FI811860L (en) SKAOLNINGSPLATTA AV TVAO DELAR SOM TILLSAMMANS BILDAR EN REKTANGEL
FI812981L (en) FOERPACKNINGS- ELLER BELAEGGNINGSMATERIAL SOM INNEHAOLLER EN FOERENING AV PETRINTYP
DK228381A (en) PROCEDURE FOR THE MANUFACTURE OF ANTI-DETAILED PHARMACEUTICAL PREPARATIONS
DK17281A (en) MICRO-hypodermic syringe
SE8003253L (en) USE OF POLYPEPTIDE FRACTIONS AS A DRUG
SE8003256L (en) USE OF POLYPEPTIME FRACTIONS AS A MEDICINE
BE874626R (en) NEW DRUG ASSOCIATION
AT377039B (en) STAIRCASE
NO813063L (en) PROCEDURE FOR THE PREPARATION OF 4-CARBAMOYLOXYOCSAZA PHOSPHORINES
FI813175L (en) FOERFARANDE FOER AOTERVINNING AV SAODANT JONBYTESHARTSMATERIAL SOM INNEHAOLLER BAODE ANJON- OCH KATJONGRUPPER
BR7900514A (en) PACKING
FI813451L (en) FOER PACKING
IT8049902A0 (en) PHARMACEUTICAL COMPOSITION
PL208373A1 (en) BRIDGE DILATATION
FI813560L (en) MEDICINE SPRIDARANORDNING
FI802549A (en) FOERFARANDE FOER FRAMSTAELLNING AV EN BIOSTIMULATOR SOM BEFRAEMJAR TILLVAEXTEN HOS JAEST
RO78607A2 (en) HIPOLIPEMIANANTE-ANTIATEROSCLEROTIC MEDICINAL COMPOSITION